[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hypertension-pulmonary-arterial\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hypertension-pulmonary-arterial":24},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,38],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":22,"conditions":23,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":26,"lastUpdatePostDateStruct":27,"startDateStruct":30,"completionDateStruct":32,"leadSponsor":34,"locationsCount":37},"100171170","pulmonary-hypertension-institutional-registry-at-hospital-italiano-de-buenos-aires-100171170",false,"NCT01501838","Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires","PH-HIBA","* Inclusion Criteria:\n\n  1. Diagnosed with PAH WHO group 1 (2022 ESC\u002FESR guidelines criteria) as the presence of a mean pulmonary artery pressure (mPAP) greater than 20 mmHg at rest with pulmonary arterial wedge pressure (PAWP) \\>15 mmHg and pulmonary vascular resistance (PVR) \\>2 WU, according to the 2022 ESC\u002FERS Guidelines for the diagnosis and treatment of pulmonary hypertension.\n  2. Included in the institutional registry of PAH of Hospital Italiano de Buenos Aires\n  3. Aged ≥18 years at the index date.\n* Exclusion Criteria History of lung transplantation surgery previously the baseline period","ALL","17 Years",{"count":19,"type":20},200,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to create a registry of patients with Pulmonary Hypertension who received medical care in the Hospital Italiano of Buenos Aires.",[24],"Hypertension, Pulmonary Arterial","RECRUITING","2025-08-19",{"date":28,"type":29},"2025-08-24","ACTUAL",{"date":31,"type":29},"2017-01-01",{"date":33,"type":20},"2031-06-01",{"name":35,"class":36},"Hospital Italiano de Buenos Aires","OTHER",1,{"id":39,"slug":40,"hasResults":11,"nctId":41,"briefTitle":42,"officialTitle":43,"acronym":4,"eligibilityCriteria":44,"healthyVolunteers":11,"sex":16,"minAge":4,"maxAge":4,"enrollmentInfo":45,"targetDuration":4,"studyType":21,"phases":4,"briefSummary":42,"conditions":46,"keywords":4,"overallStatus":25,"whyStopped":4,"lastUpdateSubmitDate":48,"lastUpdatePostDateStruct":49,"startDateStruct":51,"completionDateStruct":53,"leadSponsor":55,"locationsCount":37},"100595988","real-world-study-of-padn-for-the-treatment-of-pah-100595988","NCT07039604","Real-World Study of PADN for the Treatment of PAH","Real-World Study of Percutaneous Pulmonary Artery Denervation (PADN) for the Treatment of Pulmonary Arterial Hypertension (PAH)","Inclusion Criteria:\n\n1. Diagnosed with PAH and received PADN procedure since March 2024.\n2. No contraindications to procedure.\n3. Able to provide informed consent and authorize use of health\u002Fresearch data.\n4. Compliant with treatment and follow-up requirements.\n\nExclusion Criteria:\n\nNone specified.",{"count":19,"type":20},[47,24],"Pulmonary Hypertension","2025-06-17",{"date":50,"type":29},"2025-06-26",{"date":52,"type":29},"2025-03-19",{"date":54,"type":20},"2028-12-30",{"name":56,"class":57},"Pulnovo Medical (Wuxi) Co., Ltd.","INDUSTRY"]